We find alterations and/or reductions in expression levels of multiple tight junction and adhesion markers in ALS-CP compared to controls, including Claudin 1 and 3, Occludin and E-cadherin. The gene discussed is CLDN1; the disease is amyotrophic lateral sclerosis.